Ranbaxy develops cheaper malaria drug

08/19/2004 | NYTimes.com

India's Ranbaxy Laboratories said its new anti-malarial drug costs less but works as well as the current drug being used, artemisinin. The chief executive of Medicines for Malaria Venture said the new medicine "could be the biggest breakthrough in malaria treatment of our generation."

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Mylan Inc.
Washington, DC
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director of Actuarial Services, Government Programs
Springfield, OR
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC